alpha-glucosidase inhibitors (Shenyang Pharmaceutical University/Dalian University/Institute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences)

N/A

Report date: 2025/03/14 16:20:25
NME

Base Information

Drug Namealpha-glucosidase inhibitors (Shenyang Pharmaceutical University/Dalian University/Institute Of Chinese Materia Medica China Academy Of Chinese Medical Sciences)
Drug Alias Namemethybutyrolactone III
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A